BRS Analytical Services, LLC – FDA 483, Mar 26, 2025
BRS Analytical Services, LLC, a drug manufacturer in Saint Louis, MO, was inspected by the FDA, revealing significant deficiencies across its sterile drug product manufacturing operations. The firm failed to maintain adequate aseptic processing environments, validate critical processes like sterilization and media fills, and establish robust laboratory controls. Furthermore, the quality control unit demonstrated systemic failures in oversight, record-keeping, and adherence to fundamental GMP principles.
ID · a08e7755-f310-4d9f-9eeb-f5b976fead34
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.